Skip to main content
. 2021 Nov 24;25(1):38–46. doi: 10.1111/1756-185X.14248

TABLE 4.

Association between ultrasound and radiographic features and the secondary clinical outcomes at baseline and changes for 12 weeks

Baseline a Change from baseline to 12 week b
Coefficient (95% CI) P Coefficient (95% CI) P
Grip strength
Ultrasound‐detected synovitis −0.23 (−1.75 to 1.29) 0.77 −0.74 (−1.98 to 0.51) 0.25
Ultrasound‐detected PDS (Yes/No) 0.88 (−2.08 to 3.85) 0.56 0.49 (−1.95 to 2.93) 0.69
Ultrasound‐detected osteophyte −0.14 (−1.87 to 1.59) 0.87 0.94 (−0.48 to 2.36) 0.19
Radiographic JSN −0.05 (−1.09 to 1.00) 0.93 0.30 (−0.56 to 1.16) 0.49
Radiographic osteophytes −0.99 (−2.16 to 0.18) 0.10 −0.41 (−1.39 to 0.57) 0.41
Radiographic subchondral bone sclerosis (Yes/No) 0.40 (−1.87 to 2.68) 0.40 1.23 (−0.70 to 3.16) 0.21
Pinch strength
Ultrasound‐detected synovitis −0.01 (−0.27 to 0.24) 0.92 −0.12 (−0.34 to 0.10) 0.27
Ultrasound‐detected PDS (Yes/No) 0.07 (−0.42 to 0.57) 0.77 −0.05 (−0.48 to 0.37) 0.81
Ultrasound‐detected osteophyte −0.05 (−0.34 to 0.24) 0.72 0.01 (−0.24 to 0.26) 0.94
Radiographic JSN −0.01 (−0.19 to 0.16) 0.90 −0.00 (−0.1 5 to 0.15) 0.99
Radiographic osteophytes −0.01 (−0.20 to 0.19) 0.95 −0.11 (−0.27 to 0.06) 0.21
Radiographic subchondral bone sclerosis (Yes/No) −0.15 (−0.53 to 0.23) 0.43 −0.02 (−0.36 to 0.32) 0.91
Duration of stiffness
Ultrasound‐detected synovitis −0.75 (−5.12 to 3.62) 0.74 0.37 (−5.91to 6.66) 0.91
Ultrasound‐detected PDS (Yes/No) −2.61 (−11.13 to 5.92) 0.55 −5.57 (−17.82 to 6.68) 0.37
Ultrasound‐detected osteophyte −2.93 (−7.90 to 2.03) 0.25 6.14 (−1.00 to 13.28) 0.09
Radiographic JSN −0.44 (−3.45 to 2.56) 0.77 5.57 (1.33 to 9.80) 0.01
Radiographic osteophytes −1.27 (−4.67 to 2.14) 0.46 −0.45 (−5.35 to 4.46) 0.29
Radiographic subchondral bone sclerosis (Yes/No) −0.60 (−7.15 to 5.95) 0.86 5.17 (−4.54 to 14.89) 0.86
PGA
Ultrasound‐detected synovitis 0.11 (−4.89 to 5.12) 0.96 2.29 (−2.31 to 6.89) 0.33
Ultrasound‐detected PDS (Yes/No) −9.92 (−19.56 to 0.28) 0.04 −2.35 (−11.46 to 6.77) 0.61
Ultrasound‐detected osteophytes −0.38 (−6.09 to 5.32) 0.89 3.04 (−2.20 to 8.28) 0.25
Radiographic JSN 0.48 (−2.95 to 3.92) 0.78 4.28 (1.18 to 7.38) 0.01
Radiographic osteophytes −0.34 (−4.24 to 3.56) 0.87 0.39 (−3.21 to 3.99) 0.83
Radiographic subchondral bone sclerosis (Yes/No) −0.23 (−7.73 to7.26) 0.95 −0.90 (−8.05 to 6.25) 0.80
Aqol‐4D
Ultrasound‐detected synovitis −0.59 (−2.51 to 1.33) 0.54 0.86 (−0.53 to 2.25) 0.22
Ultrasound‐detected PDS (Yes/No) 1.25 (−2.50 to 4.99) 0.51 0.65 (−2.07 to 3.37) 0.64
Ultrasound‐detected osteophytes −1.77 (−3.94 to 0.41) 0.11 0.21 (−1.39 to 1.81) 0.80
Radiographic JSN −0.19 (−1.51 to 1.13) 0.77 −0.49 (−1.45 to 0.46) 0.31
Radiographic osteophytes −0.47 (−1.97 to 1.02) 0.53 0.42 (−0.66 to 1.51) 0.44
Radiographic subchondral bone sclerosis (Yes/No) −0.66 (−3.53 to 2.22) 0.65 1.61 (−0.54 to 3.75) 0.14

Abbreviations: AqoL‐4D, Assessment of Quality of Life‐4D instrument; CI, confidence interval; JSN, joint space narrowing; PDS, power Doppler signal; PGA, patient’s global assessment. The significance of bold values represent positive values (P <0.05).

a

Adjustment for age, sex, body mass index and duration of disease.

b

Adjustment for age, sex, body mass index, course of disease and baseline symptoms.